A17.0 Tuberculous meningitis

Name of the Condition

• Tuberculous meningitis

Summary

Tuberculous meningitis is a severe form of tuberculosis (TB) that affects the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when Mycobacterium tuberculosis bacteria spread to the central nervous system, leading to inflammation and potential neurological complications. This condition requires prompt diagnosis and treatment to prevent severe outcomes.

Causes

Tuberculous meningitis is caused by the spread of Mycobacterium tuberculosis from a primary TB infection, typically in the lungs, to the meninges. The bacteria can reach the central nervous system through the bloodstream or by direct extension from adjacent infected tissues.

Risk Factors

• Active pulmonary tuberculosis or other extrapulmonary TB
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Malnutrition or chronic illness
• Recent TB exposure or infection
• Lack of access to TB treatment or preventive care

Symptoms

• Persistent headache
• Fever and night sweats
• Stiff neck (meningitis)
• Nausea and vomiting
• Neurological deficits (e.g., weakness, numbness, confusion)
• Seizures
• Changes in mental status

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging (e.g., MRI or CT scans), and laboratory testing. Cerebrospinal fluid (CSF) analysis is critical, with findings often including elevated protein, low glucose, and the presence of TB bacteria or DNA. Cultures or molecular tests may confirm the diagnosis.

Treatment Options

• Antitubercular therapy: A multi-drug regimen (e.g., isoniazid, rifampin, pyrazinamide, ethambutol) is initiated to target the bacteria.
• Corticosteroids: May be used to reduce inflammation and prevent neurological damage.
• Supportive care: Includes managing symptoms like fever, pain, and seizures, as well as addressing complications such as hydrocephalus.

Prognosis and Follow-Up

Prognosis depends on early diagnosis and treatment. Delayed treatment increases the risk of severe neurological damage or death. Follow-up involves monitoring for treatment response, potential drug resistance, and long-term neurological sequelae. Regular clinical and imaging assessments are typically required.

Complications

• Permanent neurological deficits (e.g., hearing loss, cognitive impairment)
• Hydrocephalus
• Seizure disorders
• Death, particularly if treatment is delayed

Lifestyle & Prevention

• Complete the full course of TB treatment to prevent reactivation.
• Ensure proper ventilation in living spaces to reduce TB transmission.
• Seek prompt medical care for TB symptoms or exposure.
• Maintain good hygiene and avoid close contact with active TB cases if immunocompromised.

When to Seek Professional Help

Seek immediate medical attention if experiencing persistent headache, fever, stiff neck, or neurological symptoms (e.g., confusion, weakness), especially in the context of known TB exposure or infection.

Tips for Medical Coders

Document the presence of tuberculous meningitis with the ICD-10-CM code A17.0. Ensure clinical documentation supports the diagnosis, including symptoms, diagnostic findings (e.g., CSF analysis), and treatment. Note any associated complications or risk factors (e.g., HIV co-infection) as they may impact coding and reimbursement.